Access Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Sell
7,298
-30
-0.4% -$6.45K 0.6% 29
2026
Q1
$1.59M Sell
7,328
-147
-2% -$32.6K 0.57% 31
2025
Q4
$1.71M Sell
7,475
-167
-2% -$38K 0.62% 29
2025
Q3
$1.77M Sell
7,642
-62
-0.8% -$12.6K 0.64% 30
2025
Q2
$1.43M Buy
7,704
+290
+4% +$53.9K 0.54% 41
2025
Q1
$1.55M Buy
7,414
+101
+1% +$19.6K 0.62% 35
2024
Q4
$1.3M Buy
7,313
+75
+1% +$13.8K 0.58% 46
2024
Q3
$1.43M Sell
7,238
-1,585
-18% -$296K 0.66% 44
2024
Q2
$1.51M Sell
8,823
-80
-0.9% -$13.3K 0.69% 37
2024
Q1
$1.62M Sell
8,903
-2,401
-21% -$414K 0.72% 36
2023
Q4
$1.75M Buy
11,304
+471
+4% +$68.7K 0.9% 21
2023
Q3
$1.61M Sell
10,833
-22
-0.2% -$3.23K 0.97% 23
2023
Q2
$1.46M Sell
10,855
-100
-0.9% -$14.7K 0.85% 36
2023
Q1
$1.75M Buy
10,955
+803
+8% +$123K 1.06% 21
2022
Q4
$1.64M Sell
10,152
-632
-6% -$96.9K 1% 21
2022
Q3
$1.45M Buy
10,784
+450
+4% +$64.6K 0.94% 23
2022
Q2
$1.58M Sell
10,334
-2,381
-19% -$364K 0.91% 22
2022
Q1
$2.06M Sell
12,715
-2,000
-14% -$291K 0.98% 16
2021
Q4
$1.99M Buy
14,715
+199
+1% +$23.5K 0.9% 27
2021
Q3
$1.57M Buy
14,516
+777
+6% +$88.8K 0.71% 42
2021
Q2
$1.55M Sell
13,739
-1,067
-7% -$120K 0.72% 51
2021
Q1
$1.6M Sell
14,806
-941
-6% -$101K 0.75% 47
2020
Q4
$1.69M Buy
15,747
+111
+0.7% +$10.7K 0.83% 37
2020
Q3
$1.37M Buy
15,636
+123
+0.8% +$11.6K 0.74% 38
2020
Q2
$1.52M Sell
15,513
-65
-0.4% -$5.72K 1% 31
2020
Q1
$1.19M Buy
15,578
+229
+1% +$19.5K 0.95% 27
2019
Q4
$1.36M Buy
15,349
+16
+0.1% +$1.33K 0.79% 42
2019
Q3
$1.16M Sell
15,333
-5,879
-28% -$403K 0.83% 39
2019
Q2
$1.54M Buy
21,212
+2,242
+12% +$176K 1.18% 28
2019
Q1
$1.53M Buy
18,970
+1,671
+10% +$137K 1.2% 23
2018
Q4
$1.59M Buy
17,299
+31
+0.2% +$2.73K 1.42% 15
2018
Q3
$1.63M Buy
17,268
+2,933
+20% +$278K 1.12% 21
2018
Q2
$1.33M Sell
14,335
-51
-0.4% -$4.98K 0.94% 28
2018
Q1
$1.36M Sell
14,386
-2,974
-17% -$327K 1% 32
2017
Q4
$1.68M Sell
17,360
-1,180
-6% -$111K 1.16% 21
2017
Q3
$1.65M Sell
18,540
-3,960
-18% -$301K 1.26% 17
2017
Q2
$1.63M Sell
22,500
-345
-2% -$23.2K 1.34% 16
2017
Q1
$1.49M Buy
22,845
+1,625
+8% +$102K 1.25% 16
2016
Q4
$1.33M Buy
+21,220
New +$1.3M 1.21% 13

Other funds holding ABBV

Access Financial Services's ABBV Position: Q2 2026 in Review

Access Financial Services reduced its AbbVie (ABBV) stake by 0.41% in Q2 2026, selling an estimated $6.45K and leaving 7,298 shares worth $1.84M. The position accounts for 0.6% of the portfolio, ranked #29.

Access Financial Services first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.06M in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Access Financial Services held 7,298 shares of AbbVie worth $1.84M as of Q2 2026.
  • Access Financial Services sold 30 AbbVie shares in Q2 2026, an estimated $6.45K.
  • AbbVie made up 0.6% of Access Financial Services's portfolio in Q2 2026, its #29 holding.
  • Access Financial Services first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
  • Access Financial Services's AbbVie position peaked at $2.06M in Q1 2022.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Access Financial Services's 13F filing for Q2 2026, filed 16 Jul 2026.